Selected research
Industry Growth & Trends
Global Wearable Neuromodulation Devices Industry Growth and Trends Forecast to 2032
Market perspective
The global Wearable Neuromodulation Devices market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Wearable Neuromodulation Devices is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Wearable Neuromodulation Devices is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Wearable Neuromodulation Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Wearable Neuromodulation Devices include Brainco, NeuroSky, Muse, Halo Neuroscience, Caputron, Nerivio, Magnus, Emotiv and Thync, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Wearable Neuromodulation Devices market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Wearable Neuromodulation Devices market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Wearable Neuromodulation Devices market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Wearable Neuromodulation Devices.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Wearable Neuromodulation Devices market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Wearable Neuromodulation Devices Market by Company
Brainco
NeuroSky
Muse
Halo Neuroscience
Caputron
Nerivio
Magnus
Emotiv
Thync
Wearable Neuromodulation Devices Segment by Type
Head-mounted
Ear-mounted
Arm-mounted
Others
Wearable Neuromodulation Devices Segment by Application
Adults
Children
Wearable Neuromodulation Devices Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Wearable Neuromodulation Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Wearable Neuromodulation Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Wearable Neuromodulation Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Wearable Neuromodulation Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Wearable Neuromodulation Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Head-mounted
- Ear-mounted
- Arm-mounted
- Others
Applications
- Adults
- Children
Companies covered
- Brainco
- NeuroSky
- Muse
- Halo Neuroscience
- Caputron
- Nerivio
- Magnus
- Emotiv
- Thync
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Wearable Neuromodulation Devices Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Wearable Neuromodulation Devices Sales Estimates and Forecasts (2021-2032)
- 1.3 Wearable Neuromodulation Devices Market by Type
- 1.3.1 Head-mounted
- 1.3.2 Ear-mounted
- 1.3.3 Arm-mounted
- 1.3.4 Others
- 1.4 Global Wearable Neuromodulation Devices Market Size by Type
- 1.4.1 Global Wearable Neuromodulation Devices Market Size Overview by Type (2021-2032)
- 1.4.2 Global Wearable Neuromodulation Devices Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Wearable Neuromodulation Devices Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Wearable Neuromodulation Devices Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Wearable Neuromodulation Devices Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Wearable Neuromodulation Devices Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Wearable Neuromodulation Devices Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Wearable Neuromodulation Devices Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Wearable Neuromodulation Devices Industry Trends
- 2.2 Wearable Neuromodulation Devices Industry Drivers
- 2.3 Wearable Neuromodulation Devices Industry Opportunities and Challenges
- 2.4 Wearable Neuromodulation Devices Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Wearable Neuromodulation Devices Revenue (2021-2026)
- 3.2 Global Top Players by Wearable Neuromodulation Devices Sales (2021-2026)
- 3.3 Global Top Players by Wearable Neuromodulation Devices Price (2021-2026)
- 3.4 Global Wearable Neuromodulation Devices Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Wearable Neuromodulation Devices Major Company Production Sites & Headquarters
- 3.6 Global Wearable Neuromodulation Devices Company, Product Type & Application
- 3.7 Global Wearable Neuromodulation Devices Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Wearable Neuromodulation Devices Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Wearable Neuromodulation Devices Players Market Share by Revenue in 2025
- 3.8.3 2025 Wearable Neuromodulation Devices Tier 1, Tier 2, and Tier 3
4 Wearable Neuromodulation Devices Regional Status and Outlook
- 4.1 Global Wearable Neuromodulation Devices Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Wearable Neuromodulation Devices Historic Market Size by Region
- 4.2.1 Global Wearable Neuromodulation Devices Sales in Volume by Region (2021-2026)
- 4.2.2 Global Wearable Neuromodulation Devices Sales in Value by Region (2021-2026)
- 4.2.3 Global Wearable Neuromodulation Devices Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Wearable Neuromodulation Devices Forecasted Market Size by Region
- 4.3.1 Global Wearable Neuromodulation Devices Sales in Volume by Region (2027-2032)
- 4.3.2 Global Wearable Neuromodulation Devices Sales in Value by Region (2027-2032)
- 4.3.3 Global Wearable Neuromodulation Devices Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Wearable Neuromodulation Devices by Application
- 5.1 Wearable Neuromodulation Devices Market by Application
- 5.1.1 Adults
- 5.1.2 Children
- 5.2 Global Wearable Neuromodulation Devices Market Size by Application
- 5.2.1 Global Wearable Neuromodulation Devices Market Size Overview by Application (2021-2032)
- 5.2.2 Global Wearable Neuromodulation Devices Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Wearable Neuromodulation Devices Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Wearable Neuromodulation Devices Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Wearable Neuromodulation Devices Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Wearable Neuromodulation Devices Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Wearable Neuromodulation Devices Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Wearable Neuromodulation Devices Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Brainco
- 6.1.1 Brainco Company Information
- 6.1.2 Brainco Business Overview
- 6.1.3 Brainco Wearable Neuromodulation Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Brainco Wearable Neuromodulation Devices Product Portfolio
- 6.1.5 Brainco Recent Developments
- 6.2 NeuroSky
- 6.2.1 NeuroSky Company Information
- 6.2.2 NeuroSky Business Overview
- 6.2.3 NeuroSky Wearable Neuromodulation Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 NeuroSky Wearable Neuromodulation Devices Product Portfolio
- 6.2.5 NeuroSky Recent Developments
- 6.3 Muse
- 6.3.1 Muse Company Information
- 6.3.2 Muse Business Overview
- 6.3.3 Muse Wearable Neuromodulation Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Muse Wearable Neuromodulation Devices Product Portfolio
- 6.3.5 Muse Recent Developments
- 6.4 Halo Neuroscience
- 6.4.1 Halo Neuroscience Company Information
- 6.4.2 Halo Neuroscience Business Overview
- 6.4.3 Halo Neuroscience Wearable Neuromodulation Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Halo Neuroscience Wearable Neuromodulation Devices Product Portfolio
- 6.4.5 Halo Neuroscience Recent Developments
- 6.5 Caputron
- 6.5.1 Caputron Company Information
- 6.5.2 Caputron Business Overview
- 6.5.3 Caputron Wearable Neuromodulation Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Caputron Wearable Neuromodulation Devices Product Portfolio
- 6.5.5 Caputron Recent Developments
- 6.6 Nerivio
- 6.6.1 Nerivio Company Information
- 6.6.2 Nerivio Business Overview
- 6.6.3 Nerivio Wearable Neuromodulation Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Nerivio Wearable Neuromodulation Devices Product Portfolio
- 6.6.5 Nerivio Recent Developments
- 6.7 Magnus
- 6.7.1 Magnus Company Information
- 6.7.2 Magnus Business Overview
- 6.7.3 Magnus Wearable Neuromodulation Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Magnus Wearable Neuromodulation Devices Product Portfolio
- 6.7.5 Magnus Recent Developments
- 6.8 Emotiv
- 6.8.1 Emotiv Company Information
- 6.8.2 Emotiv Business Overview
- 6.8.3 Emotiv Wearable Neuromodulation Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Emotiv Wearable Neuromodulation Devices Product Portfolio
- 6.8.5 Emotiv Recent Developments
- 6.9 Thync
- 6.9.1 Thync Company Information
- 6.9.2 Thync Business Overview
- 6.9.3 Thync Wearable Neuromodulation Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Thync Wearable Neuromodulation Devices Product Portfolio
- 6.9.5 Thync Recent Developments
7 North America by Country
- 7.1 North America Wearable Neuromodulation Devices Sales by Country
- 7.1.1 North America Wearable Neuromodulation Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Wearable Neuromodulation Devices Sales by Country (2021-2026)
- 7.1.3 North America Wearable Neuromodulation Devices Sales Forecast by Country (2027-2032)
- 7.2 North America Wearable Neuromodulation Devices Market Size by Country
- 7.2.1 North America Wearable Neuromodulation Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Wearable Neuromodulation Devices Market Size by Country (2021-2026)
- 7.2.3 North America Wearable Neuromodulation Devices Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Wearable Neuromodulation Devices Sales by Country
- 8.1.1 Europe Wearable Neuromodulation Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Wearable Neuromodulation Devices Sales by Country (2021-2026)
- 8.1.3 Europe Wearable Neuromodulation Devices Sales Forecast by Country (2027-2032)
- 8.2 Europe Wearable Neuromodulation Devices Market Size by Country
- 8.2.1 Europe Wearable Neuromodulation Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Wearable Neuromodulation Devices Market Size by Country (2021-2026)
- 8.2.3 Europe Wearable Neuromodulation Devices Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Wearable Neuromodulation Devices Sales by Country
- 9.1.1 Asia-Pacific Wearable Neuromodulation Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Wearable Neuromodulation Devices Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Wearable Neuromodulation Devices Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Wearable Neuromodulation Devices Market Size by Country
- 9.2.1 Asia-Pacific Wearable Neuromodulation Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Wearable Neuromodulation Devices Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Wearable Neuromodulation Devices Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Wearable Neuromodulation Devices Sales by Country
- 10.1.1 South America Wearable Neuromodulation Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Wearable Neuromodulation Devices Sales by Country (2021-2026)
- 10.1.3 South America Wearable Neuromodulation Devices Sales Forecast by Country (2027-2032)
- 10.2 South America Wearable Neuromodulation Devices Market Size by Country
- 10.2.1 South America Wearable Neuromodulation Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Wearable Neuromodulation Devices Market Size by Country (2021-2026)
- 10.2.3 South America Wearable Neuromodulation Devices Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Wearable Neuromodulation Devices Sales by Country
- 11.1.1 Middle East and Africa Wearable Neuromodulation Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Wearable Neuromodulation Devices Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Wearable Neuromodulation Devices Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Wearable Neuromodulation Devices Market Size by Country
- 11.2.1 Middle East and Africa Wearable Neuromodulation Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Wearable Neuromodulation Devices Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Wearable Neuromodulation Devices Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Wearable Neuromodulation Devices Value Chain Analysis
- 12.1.1 Wearable Neuromodulation Devices Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Wearable Neuromodulation Devices Production Mode & Process
- 12.2 Wearable Neuromodulation Devices Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Wearable Neuromodulation Devices Distributors
- 12.2.3 Wearable Neuromodulation Devices Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst